CLRB · Cellectar Biosciences, Inc. · Fails to Deliver
$1.25
+0.04 (+3.31%)
At close · Oct 27
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These uncertainties raise substantial doubt about the Company's ability to continue as a going concern. The accompanying financial statements have been prepared on the basis that the Company will continue to operate as a going concern, which contemplates it will be able to realize assets and settle liabilities and commitments in the normal course of business for the foreseeable future. Accordingly, the accompanying consolidated financial statements do not include any adjustments that may result from the outcome of these uncertainties.”View the 10-Q filed Aug 13, 2026
Market Cap
$11.44M
Shares
9.45M
Volume · Oct 26
184.74K
Avg daily vol (3M)
84.84K
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-30 | 1,280 | $1.82 | $2,330 |
| 2026-09-28 | 766 | $1.80 | $1,379 |
| 2026-09-23 | 61 | $2.23 | $136 |
| 2026-09-21 | 701 | $2.38 | $1,668 |
| 2026-09-17 | 11 | $2.35 | $26 |
| 2026-09-16 | 1,782 | $2.32 | $4,134 |
| 2026-09-15 | 6 | $2.31 | $14 |
| 2026-09-11 | 2 | $2.37 | $5 |
| 2026-09-10 | 2 | $2.37 | $5 |
| 2026-09-02 | 12 | $2.46 | $30 |
| 2026-08-20 | 3,562 | $2.62 | $9,332 |
| 2026-08-10 | 315 | $2.57 | $810 |
| 2026-08-03 | 32,868 | $2.57 | $84,471 |
| 2026-07-31 | 11,885 | $2.53 | $30,069 |
| 2026-07-30 | 25,403 | $2.48 | $62,999 |
Showing 1–15 of 15 settlements